Investor FAQs

Dermira was founded in August 2010.
Dermira is incorporated in the state of Delaware.
275 Middlefield Road, Suite 150, Menlo Park, CA, 94025.
You can view our Board of Directors by visiting the “Board of Directors” section of our website.
You can view our management team by visiting the "Management Team" section of our website.
Dermira’s fiscal year ends December 31.
Dermira is traded on The NASDAQ Global Select Market under the symbol “DERM.”
Dermira went public on October 3, 2014.
As Dermira trades publicly on the NASDAQ, shares can be purchased through a stockbroker of your choice.
Dermira does not currently offer a direct stock purchase plan.
Currently, Dermira does not offer a dividend or a dividend reinvestment program.
Dermira’s CUSIP number is 24983L 10 4.
Dermira’s transfer agent is the American Stock Transfer and Trust Company (AST). You can find more information about how to contact American Stock Transfer at: http://www.amstock.com/main/nav_contactus.asp.
Please contact our transfer agent at: http://www.amstock.com/main/nav_contactus.asp. AST can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
You must send both your old and new addresses to our transfer agent, American Stock Transfer and Trust Company, http://www.amstock.com/main/nav_contactus.asp, by U.S. mail. Each stockholder in question must sign the request for an address change.
Quarterly & Annual Reports and other investor materials, when available, can be found in “Financials & Filings” in the “Investor Relations” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the “News Releases” section of our website.
For media inquiries please send an email to media@dermira.com.
You can view information on our development programs by visiting the “Technology & Pipeline” section of our website.
For investor related questions please send an email to investor@dermira.com.
Please visit the “Email Alerts” section of our corporate website and fill out our web form to be added to our distribution list.
You can reach Investor Relations by calling 650-421-7200 or sending an email to investor@dermira.com.